Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MOBQ | Common Stock | Exercise of in-the-money or at-the-money derivative security | $210K | +420K | +5.11% | $0.50 | 8.64M | Dec 30, 2024 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MOBQ | Convertible notes | Exercise of in-the-money or at-the-money derivative security | -210K | -33.79% | 412K | Dec 30, 2024 | Common Stock | 420K | $0.50 | Direct | F1, F2, F3 |
Id | Content |
---|---|
F1 | Not applicable. |
F2 | The securities listed in Table I and Table II are securities owned directly by Dr. Salkind and his wife and by a family trust. |
F3 | Includes (i) 59,211 shares underlying warrants exercisable at $60 per share, (ii) 2,333 shares underlying options exercisable at $68.48 per share, (iii) 100,000 shares underlying options exercisable at $.20 per share and (v) options to purchase 250,000 shares exercisable at $2.45 per share. |